MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00174369 · TERMINATED

Trial details

NCT number: NCT00174369
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2005-11-01
Primary completion: 2007-06-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.